Immunotherapy for Advanced Prostate Cancer (Patient Power Webcast)
Dr. Celestia Higano discusses a long-term study of Provenge, an anti-cancer vaccine for men with advanced prostate cancer that can provide a significant survival advantage for those who take the drug.
Related Links
Listen to the webcast